Topics
September 2021 | 5 Questions
5Q with Matias Iglicki, MD, PHD
Matias Iglicki, MD, PHD
July/August 2021 | 5 Questions
5Q with Aaron Nagiel, MD, PHD
Aaron Nagiel, MD, PhD
May/June 2021 | 5 Questions
5Q with Netan Choudhry, MD, FRCSC
Netan Choudhry, MD, FRCSC
October 2013 | 5 Questions
Thomas Albini, MD
Dr. Albini is an Associate Professor of Clinical Ophthalmology at Bascom Palmer Eye Institute in Miami and a member of the Retina Today Editorial Board.
September 2013 | 5 Questions
John W. Kitchens, MD
Dr. Kitchens is a vitreoretinal surgeon with Retina Associates of Kentucky in Lexington and a member of the Retina Today Editorial Board.
August 5, 2026
Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Trial of Oral NPDR Therapy
August 4, 2026
University of Iowa Research Underpins First-in-Human UK Study of Gene Therapy Targeting Rare IRD
Swedish Study Finds Small Absolute Risk of NAION Among GLP-1 Receptor Agonist Users
Opus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease
July/August 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
July/August 2026 Supplement
Editorially Independent Content, Supported With Advertising From Astellas and ZEISS
July 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
_1784132761.jpg?auto=compress,format&w=70)
